There will effectively be two prices for medicines – a public price on the pack and a discounted price agreed under Germany’s AMNOG process – with the difference reimbursed by the companies ...

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone prompts reflections on what has worked well and ...